OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1712$40.9058

Sinon Corp

Agricultural ChemicalsVerified

Sinon Corp maintains a capital structure with a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is characterized by a current ratio of 1.57, which is below the industry median of 1.80, suggesting moderate liquidity risk. The company's price-to-book ratio of 2.01 and price-to-tangible-book ratio of 2.01 indicate that the market values the company at a premium to its book value, consistent with the industry median of 2.10. Profitability metrics show that Sinon Corp's return on equity (ROE) is 12.76%, which is slightly below the industry median of 14.20%. The return on assets (ROA) is 7.11%, also below the industry median of 8.50%. These figures suggest that the company is generating returns, but at a slightly lower rate than the industry average. The company's gross profit margin is 30.5%, which is in line with the industry median of 30.0%, indicating that it is managing its production costs effectively. Sinon Corp's revenue is diversified across several segments, with the agricultural chemicals segment being the primary contributor. The company's geographic exposure is broad, with sales spanning Taiwan, mainland China, Europe, Japan, the Americas, and Southeast Asia. However, the company's revenue concentration in any single region is not disclosed, which could pose a risk if any one region experiences economic downturns or regulatory changes. The company's growth trajectory is reflected in its revenue and earnings performance. The most recent actual revenue was 17,081,389,000 TWD, and the last actual EPS was 1.60 TWD. While specific growth rates are not provided, the company's capital expenditure of -383,060,000 TWD suggests a reduction in investment, which could indicate a focus on cost optimization or a strategic shift in capital allocation. Risk factors for Sinon Corp include moderate liquidity risk, as indicated by the negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The risk assessment also highlights the importance of monitoring the company's liquidity position, as the current ratio is below the industry median. Recent events and filings do not provide specific details on Sinon Corp's recent activities, but the company's financial snapshot and valuation metrics suggest a stable financial position. The company's operating cash flow of 2,022,720,000 TWD and free cash flow of 282,277,000 TWD indicate that it is generating sufficient cash to support its operations and potentially fund future growth initiatives.

30-day price · 1712-3.20 (-7.3%)
Low$40.90High$45.10Close$40.90As of15 May, 00:00 UTC
Profile
CompanySinon Corp
Ticker1712.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Sinon Corp is a Taiwan-based company engaged in the research, development, and manufacturing of plant protection products, pesticides, fertilizers, and microbial agricultural products, alongside plastic product manufacturing and retail operations.

Classification. Sinon Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Sinon Corp maintains a capital structure with a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is characterized by a current ratio of 1.57, which is below the industry median of 1.80, suggesting moderate liquidity risk. The company's price-to-book ratio of 2.01 and price-to-tangible-book ratio of 2.01 indicate that the market values the company at a premium to its book value, consistent with the industry median of 2.10. Profitability metrics show that Sinon Corp's return on equity (ROE) is 12.76%, which is slightly below the industry median of 14.20%. The return on assets (ROA) is 7.11%, also below the industry median of 8.50%. These figures suggest that the company is generating returns, but at a slightly lower rate than the industry average. The company's gross profit margin is 30.5%, which is in line with the industry median of 30.0%, indicating that it is managing its production costs effectively. Sinon Corp's revenue is diversified across several segments, with the agricultural chemicals segment being the primary contributor. The company's geographic exposure is broad, with sales spanning Taiwan, mainland China, Europe, Japan, the Americas, and Southeast Asia. However, the company's revenue concentration in any single region is not disclosed, which could pose a risk if any one region experiences economic downturns or regulatory changes. The company's growth trajectory is reflected in its revenue and earnings performance. The most recent actual revenue was 17,081,389,000 TWD, and the last actual EPS was 1.60 TWD. While specific growth rates are not provided, the company's capital expenditure of -383,060,000 TWD suggests a reduction in investment, which could indicate a focus on cost optimization or a strategic shift in capital allocation. Risk factors for Sinon Corp include moderate liquidity risk, as indicated by the negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The risk assessment also highlights the importance of monitoring the company's liquidity position, as the current ratio is below the industry median. Recent events and filings do not provide specific details on Sinon Corp's recent activities, but the company's financial snapshot and valuation metrics suggest a stable financial position. The company's operating cash flow of 2,022,720,000 TWD and free cash flow of 282,277,000 TWD indicate that it is generating sufficient cash to support its operations and potentially fund future growth initiatives.
Key takeaways
  • Sinon Corp has a conservative debt-to-equity ratio of 0.28, indicating a relatively low leverage position.
  • The company's ROE of 12.76% is slightly below the industry median, suggesting room for improvement in profitability.
  • The company's liquidity position, as measured by the current ratio of 1.57, is below the industry median, indicating moderate liquidity risk.
  • Sinon Corp's revenue is diversified across multiple segments and geographic regions, reducing exposure to any single market.
  • The company's capital expenditure of -383,060,000 TWD suggests a reduction in investment, which could be a strategic move to optimize costs.
  • The company's market price of 40.9 TWD and market cap of 17,198,122,800 TWD indicate a premium valuation relative to its book value.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$18.61B
Gross profit$5.67B
Operating income$1.30B
Net income$1.09B
R&D
SG&A
D&A
SBC
Operating cash flow$2.02B
CapEx-$383.1M
Free cash flow$282.3M
Total assets$15.37B
Total liabilities$6.80B
Total equity$8.57B
Cash & equivalents$391.0M
Long-term debt$2.44B
Valuation
Market price$40.90
Market cap$17.20B
Enterprise value$19.24B
P/E15.7
Reported non-GAAP P/E
EV/Revenue1.0
EV/Op income14.8
EV/OCF9.5
P/B2.0
P/Tangible book2.0
Tangible book$8.57B
Net cash-$2.04B
Current ratio1.6
Debt/Equity0.3
ROA7.1%
ROE12.8%
Cash conversion1.9%
CapEx/Revenue-2.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1712Activity
Op margin7.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin30.5%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity28.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS1.60 TWD
Last actual revenue17,081,389,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 23:35 UTC#e5707171
Market quoteclose TWD 40.90 · shares 0.42B diluted
no public URL
2026-05-15 23:37 UTC#d090d718
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 23:39 UTCJob: fed492b2